The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Open accessAbstract
Activated natural killer (NK) cells engage in a robust metabolic response that is required for normal effector function. Using genetic, pharmacological and metabolic analyses, we demonstrated an essential role for Srebp transcription factors in cytokine-induced metabolic reprogramming of NK cells that was independent of their conventional role in the control of lipid synthesis. Srebp was required for elevated glycolysis and oxidative phosphorylation and promoted a distinct metabolic pathway configuration in which glucose was metabolized to cytosolic citrate via the citrate-malate shuttle. Preventing the activation of Srebp or direct inhibition of the citrate-malate shuttle inhibited production of interferon-γ and NK cell cytotoxicity. Thus, Srebp controls glucose metabolism in NK cells, and this Srebp-dependent regulation is critical for NK cell effector function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, it was demonstrated that the citrate–malate shuttle performs functions beyond that of an electron shuttle and, in fact, supports continuous citrate regeneration and TCA cycle intermediate homeostasis (119, 121).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [119]
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Huang, S. C., Everts, B., Ivanova, Y., O’Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W. L., Love-Gregory, L. D., Lam, W. Y., O’Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,256
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,081
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Arnold, M., Pandeya, N., Byrnes, G. B., Renehan, A. G., Stevens, G. A., Ezzati, M., Ferlay, J., Miranda, J. J., Romieu, I., Dikshit, R. P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71123-4 · Cited by 997
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3704 · Cited by 927
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–375 of 375
Autofluorescence lifetime imaging classifies human B and NK cell activation state
Schmitz, R. L., Riendeau, J. M., Tweed, K. E., Rehani, P. R., Samimi, K., Pham, D. L., Jones, I., Maly, E. M., Guzman, E. C., Forsberg, M. H., et al. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1557021 · Cited by 3
Zhao, Y., Wang, Y., Liang, T., Song, X., Zhu, Y., Liu, X., Lv, M., Zheng, C., & Ni, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114566 · Cited by 3
Jedlička, M., Feglarová, T., Švubová, V., Mašínová, E., Graman, V., Kuglerová, K., Szabová, J., Jahan, F., Korhonen, M. O., Kuželová, K., et al. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00470-w · Cited by 3
NK Cells and ILC1s in Cancer Biology
Sliz, A., & Yokoyama, W. M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8387-9_4 · Cited by 3
Tumor metabolic crosstalk and immunotherapy
Zhang, Y., Nie, Y., Liu, X., Wan, X., Shi, Y., Zhang, K., Wu, P., & He, J. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03304-4 · Cited by 3
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapies
Wolf, D. G. F., Salcher, S., & Pircher, A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178331 · Cited by 3
Dai, Z., & Liu, P. (2021) · doi:10.21203/rs.3.rs-100256/v2 · Cited by 3
Barra, C. D., Ryan, E. M., Sugrue, M., Ryan, O. K., Lynn, E., Heneghan, H., McCarthy, C., Moynagh, P. N., Sinclair, L. V., Jones, N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.10.575005 · Cited by 3
Farkas, A. M., Youssef, D., Tran, M. A., Balan, S., Newman, J. H., Audenet, F., Anastos, H., Velazquez, L. G., Peros, A., Ananthanarayanan, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.30.591366 · Cited by 3
Morris, G., & Maes, M. (2021) · Preprints.org · doi:10.20944/preprints202105.0180.v1 · Cited by 3
Amino acid and cholesterol metabolism in innate immunity
Li, W., Jin, M., Li, H., Zhong, R., Lin, Z., Shen, M., & Wang, H. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.09.019 · Cited by 3
Yu, L., Jiang, Y., Liu, X., Yan, F., Yan, H. P., Xie, Y., Shi, W., Shang, Z., Du, J., & Yang, Z. (2026) · Immunology · doi:10.1111/imm.70095 · Cited by 2
Transcriptional networks weaving natural killer anti-tumor immune response
Redavid, A. R., BIGLIARDI, M., Ciarrocchi, A., & Reggiani, F. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02643-4 · Cited by 2
Hybrid Metabolic Activity-Related Prognostic Model and Its Effect on Tumor in Renal Cell Carcinoma
Yu, L., Ding, L., Wang, Z.-Y., Zhao, X.-Z., Wang, Y.-H., Liang, C., & Li, J. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/1147545 · Cited by 2
Species-specific serine metabolism differentially controls natural killer cell functions
Li, J. H., Feng, Q., Ball, A. B., Lee, C. D., Wallerius, M. L., Bormin, J. G., Kapelczak, E. D., Armstrong, W. R., Hermans, L., Krall, A. S., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01348-0 · Cited by 4
Targeting natural killer cells in cancer immunotherapy
Matosevic, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00003-8 · Cited by 2
Inhibition of eEF-2K Enhances the Antitumor Efficacy of NK Cells
Liu, X., Liu, X., Jiang, P., Qi, X., Ma, X., Zhang, X., Proud, C. G., & Li, J. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-1001 · Cited by 1
Osuna-Espinoza, K. Y., Mejía-Torres, M., Camacho-Ortiz, A., Pérez-Alba, E., Martínez-Castilla, A. M., Salinas-Carmona, M., & Rosas-Taraco, A. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1636463 · Cited by 1
Yu, X., Zhou, J., Lei, J., Ge, H., Zhang, Z., Fu, Y., Han, X., Hu, Q., Ding, H., Geng, W., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08039-4 · Cited by 1
Chu, M. K. C., & Tong, M. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2025.69 · Cited by 1
Scap stabilizes PKM2 to promote glycolysis and enhance anti-fungal immunity in macrophages
Huang, J., Wang, Y., Li, F., Zhang, N., Tian, G., Guo, D., Guo, Y., Liu, Z., Wu, Y., Li, X., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117106 · Cited by 2
Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia
Giorgetta, S., Cortopassi, F., Chanis, T., Ni, J., Correia, M. P., Sticht, C., Ast, V., Platten, M., Cerwenka, A., & Stojanovic, A. (2026) · iScience · doi:10.1016/j.isci.2026.115492 · Cited by 1
A Microbial Lipid‐ATP Synthase Axis Fuels NK Cell Antitumor Activity
Yu, K., Sun, X., Ma, W., Yang, J., Sun, X., Zhang, L., Liu, Y., Ren, T., Wang, Q., Wang, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202520095 · Cited by 1
Effects of CMV on T and NK Cells; With Emphasis on Immunometabolism
Namdari, H., Keshavarz, M., Hosseini, M., Parvizpour, F., Emami, A., Izadi, E., Asl, M. S., Shahgolzari, M., & Rezaei, F. (2026) · BioMed Research International · doi:10.1155/bmri/7838997 · Cited by 1
CAR-NK cell therapy for hematological malignancies
Manzar, G. S., Hasan, M. F., Moore, M., Tiberti, S., Başar, R., & Daher, M. (2026) · Blood Advances · doi:10.1182/bloodadvances.2024014082 · Cited by 2
Benezech, S., Picq, L., Villard, M., Rousseaux, N., Hamond, A., Allatif, O., Bal, A., Bélot, A., Trouillet‐Assant, S., Marçais, A., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag036 · Cited by 1
Metabolic remodeling of endometriosis microenvironment: Energy stress and immune evasion
Yang, P., Wang, T., Liu, W., Miao, Y., Zhu, Y., & Sun, J. (2026) · iScience · doi:10.1016/j.isci.2026.116592 · Cited by 1
Xu, T., Xu, M., Xu, Y.-Y., Cai, X.-J., Brenner, M. J., Twigg, J. A., Fei, Z.-D., & Chen, C.-B. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2345 · Cited by 2
Unger, Z., Kuklinski, A., & Gómez‐Casado, C. (2024) · Allergy · doi:10.1111/all.16134 · Cited by 1
Role of Metabolism in Supporting Immune Responses
Susarla, S., Erbay, M. İ., Johanis, A., Abuelazm, M. T., & Ghanem, A. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_8 · Cited by 1
Natural Killer Cell-Based Immunotherapy against Solid Cancer
Lv, P., Li, W., Wang, R., Huang, G., Zhu, Y., & Tao, Q. (2021) · OALib · doi:10.4236/oalib.1107056
Cytokine-driven role of Srebps in killer cell metabolism
Guillerey, C., & Smyth, M. J. (2017) · Nature Immunology · doi:10.1038/ni.3855
SREBP1 regulates mitochondrial metabolism in oncogenic KRAS expressing NSCLCPreprint
Ruiz, C. F., Montal, E. D., Haley, J. D., & Haley, J. D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.15.896373
NK cell-mediated immunotherapy: The exquisite role of PGC-1a in metabolic reprogramming
Gerbec, Z. J., & Malarkannan, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00006-0
Immunometabolic targeting of NK cells to solid tumors
Lupo, K. B., & Matosevic, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00015-1
Targeting metabolism to potentiate NK cell-based therapies
Dhar, P., & Wu, J. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00016-3
Witkowski, J. M., & Fülöp, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00183-x
Anand, P. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736179682.793588171
Dietary components associated with being overweight, having obesity, and cancer
Anisman, H., & Kusnecov, A. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91904-3.00018-5
Kasotakis, G., & Stanfield, B. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738515967.793580913
Immune Cell Metabolism and Function
Dixit, A. K., & Singh, M. P. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_1
Targeting the Immuno-Oncology Metabolism in Cancer
Tripathi, S. C., Fahrmann, J. F., & Amle, D. B. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_5
Immune Cell Metabolites as Fuel for Cancer Cells
Aggarwal, V., Rathod, S., Vashishth, K., & Upadhyay, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_6
Zhang, Y., Zeng, Y., Song, S., Zhang, Z., & Chen, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2765540/v1
Tejera, C. M. (2023) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/59773
Yu, X., Li, S., Qin, J., Zhao, Y., & Wang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3140844/v1
Metabolic regulation of natural killer functions
Orlova, E. G. (2023) · Вестник Пермского университета. Серия: Биология · doi:10.17072/1994-9952-2023-1-83-94
Spiteri, A. G., Wishart, C. L., Pinget, G. V., Purohit, S. K., Macia, L., King, N. J. C., & Niewold, P. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12739
Yu, X., Zhou, J., Lei, J., Ge, H., Zhang, Z., Fu, Y., Han, X., Hu, Q., Ding, H., Geng, W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.31.596765
Dietary alterations to induce antitumor immunity
Saha, S., & Montrose, D. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00028-x · Cited by 1
The Immunometabolism of Natural Killer Cell Responses
Keane, C., Gardiner, C. M., & Finlay, D. K. (2025) · Springer eBooks · doi:10.1007/978-3-662-68816-8_41-1
Self-citationCellular Metabolism Controls Lymphocyte Activation and Differentiation
Powell, J. D., & Sun, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00180-0
Puertas-Umbert, L., Alonso, J., Blanco-Casoliva, L., Bentanachs, R., Asmarats, L., Arderiu, G., Martínez‐González, J., & Rodrı́guez, C. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500856
Fu, Y., Chen, Y., Xie, Z., Huang, H., Tan, W.-S., & Cai, H. (2022) · Figshare · doi:10.6084/m9.figshare.20678781
Tumor-Infiltrating Natural Killer Cells—Challenges and Strategies
Marquardt, N., Alici, E., & Meinke, S. (2025) · Springer eBooks · doi:10.1007/978-3-662-68816-8_70-1
Modular to cyclic TCA governs hematopoiesis in DrosophilaPreprint
Tomar, A., Chakrabarti, S., & Mukherjee, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.04.692477
Glutathione is critical for NK cell-mediated immunity
Guerra, L., Grusdat, M., Kobayashi, T., Longworth, J., Kurniawan, H., Franchina, D. G., Theodorakis, G., Binsfeld, C., Verschueren, C., Bonetti, L., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.116986
Brigleb, P. H., Frank, M. B., Rowland, L., Bub, T., Guy, C. S., Livingston, B., Mandarano, A. H., Sekera, E. R., Bowling, J. J., & Schultz‐Cherry, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.06.710186
Puertas-Umbert, L., Alonso, J., Blanco-Casoliva, L., Bentanachs, R., Asmarats, L., Arderiu, G., Martínez-González, J., & Rodriguez, C. R. (2026) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2026.500856
Corral, D. (2020) · theses.fr (ABES) · doi:10.70675/5891ec8az223cz458dzb5cezd92ba38e80aa
The anti-tumoral effects of a low protein diet and of the IRE1α signaling
Turtos, A. M. (2022) · theses.fr (ABES) · doi:10.70675/fd90a3e8ze35az42fdzbd0ez966f12ddad22
Endoplasmic Reticulum Associated Lipolysis Regulates Hepatic Fat Synthesis and TurnoverPreprint
Lian, J., Watts, R., Nelson, R., Kennelly, J. P., Thiesen, A., Quiroga, A. D., Vine, D. F., Clugston, R. D., Jacobs, R. L., & Lehner, R. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.08.723884
Role of Natural Killer Cells in Atherosclerosis and Vascular Inflammation
Carrega, P., Ferlazzo, G., & Bonaccorsi, I. (2026) · Springer eBooks · doi:10.1007/978-3-662-68816-8_34-1
Tumour microenvironments impose translational repression that limits natural killer cell persistencePreprint
de Aguiar, C. F., Nosenko, M. A., Corkish, C., Keane, C., Skabytska, Y., Gardiner, C. M., Brennan, L., Sinclair, L. V., & Finlay, D. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.06.736719
Self-citationIntracellular metabolic regulation of the fate and function of innate lymphoid cells
Wang, J., Chen, B., & Ren, W. (2026) · Trends Open · doi:10.1016/j.treopn.2026.06.011
Targeting metabolic reprogramming in cancer: Past, present, and future
Kumari, N., Shukla, S. K., & Thakur, R. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109109
Riendeau, J. M., Hockerman, L., Maly, E. M., Samimi, K., & Skala, M. C. (2026) · Biophotonics discovery. · doi:10.1117/1.bios.3.3.035003
Shams, U. A., Inayat, F., Zeb, M. A., Maryam, Shams, S., Ullah, M. J., & Jiménez‐Morales, S. (2026) · Pharmaceuticals · doi:10.3390/ph19091384
Matteo, S. D., & Gnocchi, D. (2026) · Biology · doi:10.3390/biology15191790
Gu, X., 吕英慧, Wang, L., Nan, D., Chunxia, Z., & Gong, D. (2026) · The FASEB Journal · doi:10.1096/fj.202601873rr
Next-generation natural killer cell therapy: bench to bedside and beyond
Zhao, A., Xu, J., Deng, W., Zhang, M., Shao, Y., Liu, Y., Liang, A., Wang, X., Niu, T., & Qian, W. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02911-1
Metadata
- Authors
- Assmann, N., O'Brien, K. L., Donnelly, R. P., Dyck, L., Zaiatz-Bittencourt, V., Loftus, R. M., Heinrich, P., Oefner, P. J., Lynch, L., Gardiner, C. M., Dettmer, K., & Finlay, D. K.
- Affiliations
- Trinity College Dublin (IE)
- University of Regensburg (DE)
- Corresponding author
- Finlay, David K
- ORCID
- Venue
- Nature Immunology
- Published
- 2017-09-18
- Volume
- 18
- Issue
- 11
- Pages
- 1197-1206
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2755907400
- Cited by
- 375
- References
- 57
- Citations by year
- 2026: 35 · 2025: 54 · 2024: 37 · 2023: 44 · 2022: 53 · 2021: 57 · 2020: 45 · 2019: 25 · 2018: 21 · 2017: 4
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- natural killer cells, SREBP, glucose metabolism, metabolic reprogramming, glycolysis, oxidative phosphorylation, interferon-gamma, NK cell cytotoxicity, cytokine activation, antitumor immunity, viral infection
- MeSH terms
- Animals, Flow Cytometry, Glucose, Glycolysis, Humans, Killer Cells, Natural, Lipids, Oxidative Phosphorylation, Immunoblotting, T-Lymphocyte Subsets, Cytokines, Cell Proliferation, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review